First new anti-malaria drug in 25 years developed
Scientists unveil GanLum, a groundbreaking malaria treatment with a 97% cure rate. Developed to combat drug resistance, it's hailed as the biggest advance in decades. Read the full story.
Category : Search result: Novartis
Breakthrough malaria treatments combat drug resistance
Researchers announce two promising malaria treatments as drug resistance grows. New approaches could revolutionise treatment in affected regions. Read the latest developments.
New Malaria Drug Shows 97% Cure Rate in Trial
Novartis develops first new anti-malaria treatment in 25 years, demonstrating over 97% efficacy against drug-resistant parasites. Could transform global malaria control.
New Malaria Drug Shows 97% Cure Rate
Scientists unveil a revolutionary malaria treatment with a 97% cure rate, potentially the biggest advance in decades. Learn how this could transform global health.
New cholesterol jab cuts heart attack risk by 27%
A groundbreaking 'game-changer' drug, Inclisiran, has proven highly effective in reducing heart attacks and strokes in a major NHS study, offering new hope for millions with high cholesterol.
Novartis Accused of Exploiting WHO Scheme in Africa
An explosive investigation reveals how pharmaceutical giant Novartis leveraged a WHO-led initiative to push its expensive cancer drug in Nigeria and Kenya, raising serious ethical concerns about Big Pharma's role in public health.
EU probes Swiss pharma over Trump-era deals
European Union investigates Swiss pharmaceutical firms Roche and Novartis for potential antitrust violations in deals connected to Donald Trump's administration.
Trump's Cambodia and Canada remarks cause diplomatic stir
Former US President Donald Trump faces backlash after making inflammatory comments about Cambodia and Canada, reigniting debates on diplomacy and international relations.
Page 1 of 1